Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Environmental Research|September 27, 2020
Predicting the environmental emissions arising from conventional and nanotechnology-related pharmaceutical drug productsFabian Jung, Manuela Thurn, Katharina Krollik, et al.
Frontiers in Pharmacology|July 14, 2022
The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical ImplicationsAmir Hossein Miri, Mojtaba Kamankesh, Antoni Llopis-Lorente, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 21, 2018
Stimulating brain recovery after stroke using theranostic albumin nanocarriers loaded with nerve growth factor in combination therapyTivadar Feczkó, Albrecht Piiper, Saema Ansar, et al.
Molecules (Basel, Switzerland)|February 10, 2021
Exploring the Interplay between Drug Release and Targeting of Lipid-Like Polymer Nanoparticles Loaded with DoxorubicinTatyana Kovshova, Nadezhda Osipova, Anna Alekseeva, et al.
International Journal of Pharmaceutics|July 1, 2015
Nanocarriers for photodynamic therapy-rational formulation design and medium-scale manufactureMônica Villa Nova, Christine Janas, Mike Schmidt, et al.
Nanoscale|August 29, 2020
Micro cell vesicle technology (mCVT): a novel hybrid system of gene delivery for hard-to-transfect (HTT) cellsYi-Hsuan Ou, Shui Zou, Wei Jiang Goh, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|April 2, 2021
Microparticle formulations alter the toxicity of fenofibrate to the zebrafish Danio rerio embryoIndra Hering, Elke Eilebrecht, Michael J Parnham, et al.
ACS Nano|February 15, 2024
A Design-Conversed Strategy Establishes the Performance Safe Space for Doxorubicin NanosimilarsShakti Nagpal, Jordan Png Yi Jie, Julia Malinovskaya, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 11, 2023
Future Nanotechnology-Based Strategies for Improved Management of Helicobacter pylori InfectionMojtaba Kamankesh, Abbas Yadegar, Antoni Llopis-Lorente, et al.
International Journal of Pharmaceutics|September 5, 2021
Injectable drug delivery systems of doxorubicin revisited: In vitro-in vivo relationships using human clinical dataHarshvardhan Modh, Daniel Juncheng Fang, Yi Hsuan Ou, et al.
Pageof 7